What is the recommended workup for a suspected endometrioma, including history, pelvic exam, imaging, labs, and management steps?

Endometrioma Workup

For suspected endometrioma, transvaginal ultrasound (TVUS) is the primary imaging modality, with MRI pelvis (with or without contrast) reserved for indeterminate cases or surgical planning. 1, 2, 3

Clinical Evaluation

History

Focus on specific symptoms that suggest endometriosis:

• Chronic pelvic pain (present in majority of cases)
• Dysmenorrhea (acquired, progressive)
• Dyspareunia (deep)
• Dyschezia (painful bowel movements)
• Infertility (affects up to 44% of women with endometriomas) 4
• Menstrual irregularities or heavy bleeding

Document age, menopausal status, and fertility goals, as these directly impact management decisions 4.

Physical Examination

The pelvic examination must include 5, 6:

• Speculum examination to visualize vaginal lesions
• Bimanual palpation assessing:
  • Uterine mobility, fixation, or tenderness
  • Adnexal masses or tenderness
  • Site-specific tenderness in posterior fornix (uterosacral ligaments)
  • Nodularity in the posterior cul-de-sac
  • Rectovaginal examination for posterior compartment involvement

Imaging Workup

First-Line: Transvaginal Ultrasound

TVUS is the primary diagnostic imaging modality and should follow the IDEA (International Deep Endometriosis Analysis) consensus approach 3, 7:

Classic endometrioma features on TVUS 1:

• Ground-glass or homogeneous low-level echoes (most specific finding)
• Unilocular or multilocular cyst
• Visible surrounding ovarian parenchyma
• Posterior acoustic enhancement
• No internal vascularity on color Doppler (critical feature)
• Occasionally peripheral punctate echogenic foci without shadowing

Size documentation is critical for risk stratification:

• <10 cm: O-RADS 2 (almost certainly benign) if classic features present 1
• ≥10 cm: O-RADS 3 (low risk, 1-10% malignancy risk) even with classic features 1

Additional TVUS assessment should include 3, 7:

• Evaluation for adenomyosis (using MUSA criteria)
• Assessment of ovarian mobility ("sliding sign")
• Evaluation of deep infiltrating endometriosis in anterior/posterior compartments
• Bilateral kidney assessment (mandatory when endometrioma suspected to detect silent hydronephrosis from ureteric involvement) 3

Second-Line: MRI Pelvis

MRI is indicated when 8, 9, 2:

• TVUS findings are indeterminate
• Surgical planning required for deep infiltrating endometriosis
• Large masses (≥10 cm) need better characterization
• Fertility-sparing treatment being considered
• Obesity limits TVUS visualization

MRI protocol 2, 10:

• Multiplanar T2-weighted sequences
• T1-weighted sequences (with and without fat saturation)
• Diffusion-weighted imaging (DWI) improves diagnostic accuracy
• Contrast administration: MRI with IV contrast preferred for comprehensive evaluation, though MRI without contrast acceptable if contrast contraindicated 2, 11
• Include kidney visualization sequences

Classic endometrioma MRI features 8, 9:

• High T1 signal with low T2 signal ("T2 shading" or "T2 dark spot sign")
• Specificity of T2 dark spot sign: 93% for differentiating from hemorrhagic cysts 8
• Lack of enhancement in cyst contents (solid components should enhance if present)

Laboratory Testing

No routine laboratory tests are diagnostic for endometrioma 12:

• CA-125 is NOT recommended for diagnosis 12, 13
  • May be falsely elevated in premenopausal women with endometriosis
  • Can cause unnecessary concern for malignancy
  • Only useful for monitoring known malignancy, not diagnosis

Risk Stratification Using O-RADS Classification

O-RADS 2 (Almost certainly benign, <1% malignancy risk) 1:

• Typical endometrioma <10 cm with ground-glass echoes
• Management: US specialist, gynecologist, or MRI if enlargement, changing morphology, or developing vascular component
• Optional single follow-up in one year

O-RADS 3 (Low risk, 1-<10% malignancy risk) 1:

• Typical endometrioma ≥10 cm
• Management: General gynecologist (no oncology consultation needed); consider US specialist or MRI for optimal characterization

O-RADS 4 or 5 (Intermediate to high risk) 1:

• Endometrioma with atypical features (solid components, high vascularity, irregular walls)
• Management: Gynecologic oncology consultation required

Management Algorithm Based on Findings

Confirmed Endometrioma on Imaging

Size-based approach 14:

• <3 cm: Conservative management if asymptomatic; medical therapy for pain
• 3-5 cm:
  • If causing pain/infertility: surgical excision
  • If asymptomatic: surveillance or medical therapy
• ≥5 cm:
  • Surgical excision recommended before assisted reproductive technology
  • Excision preferred over drainage/ablation for better outcomes 14

Surgical planning considerations 4, 14:

• Laparoscopic cystectomy is gold standard
• Minimize bipolar energy use to preserve ovarian reserve
• Postoperative hormonal therapy reduces recurrence
• Document antimüllerian hormone (AMH) and antral follicle count pre-operatively if fertility desired

Indeterminate Lesions

Proceed to MRI pelvis (with contrast if feasible) for definitive characterization 9, 2, 11

Critical Pitfalls to Avoid

1. Do not rely on CA-125 for diagnosis—it lacks specificity and can mislead management 12, 13

2. Do not miss bilateral kidney assessment—ureteric involvement occurs in 5-10% of deep endometriosis cases 3

3. Do not assume absence of Doppler flow excludes solid tissue—consider lesion "solid-appearing" and upgrade risk category 1

4. Postmenopausal endometriomas have increased malignancy risk—lower threshold for surgical intervention 1

5. Do not perform surgery for diagnosis alone—preoperative imaging with TVUS and/or MRI is mandatory 3, 6

6. Ultrasound cannot definitively exclude endometriosis—negative imaging does not rule out superficial peritoneal disease 3, 7